John P. Gilbride, Email and Phone Number
John P. Gilbride, work email
- Valid
- Valid
- Valid
John P. Gilbride, personal email
- Valid
Experienced Director of Ethics and Compliance with a demonstrated history of working in the pharmaceutical industry. Former Executive Officer - Special Agent in Charge of DEA’s largest office - New York. Skilled in all aspects of pharmaceutical security - Suspicious Order Monitoring, Import/ Export Due Diligence, Supply Chain Security, Drug Diversion Prevention, Control Substance Compliance, DEA Regulations, Physical and Personnel Security, Internal Investigations, Business Continuity Planning, Crisis Management, Budget Analysis, Risk Management, Intelligence Collection, and Training. Strong administrative professional with an MA in Human Resource Training and Development from Seton Hall University.
-
Director Ethics And CompliancePurdue Pharma L.P. Sep 2020 - PresentStamford, Ct, UsProvide overall strategic direction for Purdue’s Suspicious Order Monitoring (SOM) programProvide updates to court appointed monitor and Purdue Pharma’s Law Department on Suspicious Order Monitoring topics.Provide oversight to ensure compliance with voluntary injunction relating to Suspicious Order Monitoring.Manage third-party vendor relationshipsIdentify trends based on monitoring activities that will help inform training needsSupport departmental and cross-functional compliance projects as neededReview of responses to medical information requestsReview of responses to customer service requestsMonitor, maintain and update the algorithm used to analyze controlled substance ordersCommunicate on a regular basis with pharmaceutical wholesalers on controlled substance orders of interestLiaison to the Drug Enforcement Administration regarding suspicious order reportingSupervise and direct staff responsible for evaluation of pended ordersDirect team responsible for regular review of downstream customer dataOversee Export Control processes, reviewing requests for ex-US shipments of US labeled productsEnsure that the company is proactive in its SOM and customer due diligence effortsSupervise data analysis efforts to detect anomalies in order and prescription data, implementing best practices -
Director Corporate SecurityPurdue Pharma L.P. Apr 2015 - Sep 2020Stamford, Ct, UsDevelop, implement and monitor policies and procedures that will insure the security of Purdue products throughout the entire supply chain, both domestically and internationally. Principle liaison with local, state, and federal law enforcement officials and agencies relating to Purdue supply chain security programs.Conduct due diligence site security surveys/audits, of most if not all, potential and existing business partners (transportation providers, vendors and customers). Obtain, research and disseminate supply chain security intelligence. Ensures C-TPAT compliance.Provides and/or coordinates training on the prevention of abuse, and diversion of pharmaceutical products (Pharmacy Safety and Security, Lawful Prescribing, Pharmacology, Abuse and Diversion, Counterfeit Pharmaceuticals, Clandestine Fentanyl, Insurance Fraud and Drug Diversion, and Institutional Diversion).Conduct and/or coordinate investigations into events that involve supply chain issues. Ensures operations are carried out in full compliance of DEA regulations for the processing of controlled substances and other applicable FDA regulations.Maintains liaison with DEA and field elements.Interacts with DEA on company-wide suspicious order monitoring program.Ensures controlled substance compliance.Ensures DEA inspection readiness.Services as Subject Matter Expert for diversion and regulatory matters. -
Global Head Of Financial IntelligenceMorgan Stanley Jun 2014 - Apr 2015New York, Ny, UsAnalyze trends and patterns in alerts for AML and other parts of Compliance and effectively employ advanced analytic tools enterprise wide Query and mine large data sets to discover transaction patterns, examine financial data and filter for targeted information using traditional as well as predictive/advanced analytic methodologies Liaise with Business and Compliance teams to analyze trends in suspicious activity Ensure that all analysis is completed in a timely and efficient manner, while maintaining the highest standards for regulatory and compliance requirements Conduct cross-sector reviews among multiple business lines Recommend enhancements to key components of the Transaction Monitoring System as required Develop, maintain and review the FIU’s policies, procedures and processes to ensure compliance with applicable internal, legal and regulatory standards. Responsible for coordinating with AML coverage managers on the escalation and reporting of suspicious transactions pursuant to regulatory obligations Support the AML Program through production of key performance indicators (metrics) and other reporting Serve as a liaison with Compliance IT and other key stakeholders and partners with respect to technology projects and other initiatives impacting the FIU Monitor AML industry developments, including red flags and best practices and maintain advanced knowledge of new and amended laws and regulations impacting the FIU, and ensure processes are in place to keep the FIU team updated on such developments Conduct internal and external investigations of money laundering and other financial crimes both alone and in collaboration with other internal stakeholders and outside counsel -
Director Controlled Substance Compliance/Law Enforcement Liaison And EducationPurdue Pharma Sep 2011 - Jun 2014Develop and implement standards of compliance for all operating units of Purdue and Associated Companies to assure consistency between sites and full compliance with all Federal, Corporate and State Regulations impacting on Controlled Substances Act (CSA), Code of Federal Regulations (CFR) and Drug Enforcement Administration (DEA) regulated operations. Schedule and conduct periodic site audits where controlled substances are held to assure that appropriate and regulatory required processes and procedures are being observed and are contemporary.Provide guidance on CSA compliance matters to site operational units according to corporate standards. Direct and coordinate programs and functions of employees engaged in CSA, CFR compliance.Establish procedures and systems in conformance with corporate policies to facilitate achievement of company objectives while reducing or eliminating compliance risk. Responsible for corporate CSA (Controlled Substances Act) regulatory compliance programs and operations to support manufacturing, packaging, and distribution of controlled drug products.Direct all activities of the Law Enforcement Liaison & Education group who advise and educate police and healthcare personnel in the area of lawful prescribing, security of controlled substances, detecting abuse and preventing fraud relating to unlawfully obtaining controlled substances.Create and maintain positive professional relationships with law enforcement, healthcare agencies and associations, and internal stakeholders.Manage media inquiries and participate in interviews regarding law enforcement and healthcare education, as well as all aspects of the RxPatrol/Crime Stoppers program.Direct the development and revision of training programs and materials.Establish mechanisms for ongoing liaison with Corporate Security, Internal Audit, Special Projects, Regulatory Affairs, Law and International counterparts.
-
Special Agent In Charge New York OfficeDrug Enforcement Administration Apr 2005 - Sep 2011Springfield, Virginia, UsDept of Justice Senior Executive Service. Served as Chief Executive for DEA’s largest office with over 1,000 Special Agents, Diversion Investigators, NYPD Detectives, Sergeants, Lieutenants, and a Deputy Inspector, New York State Police Investigators, Lieutenants and a Captain, Intelligence Research Specialists and support staff, 11 facilities throughout New York State, as well as a 15,000 sq. ft. warehouse, with accountability for a $35 million annual budget. Oversee international narcotic, financial and pharmaceutical/fraud investigations, pharmaceutical regulation, personal, operational and facility security, DEA’s chief spokesperson conducting both print and electronic media interviews on drug issues, drug abuse, international narco-terrorism and money laundering. Management oversight of the Organized Crime Strike Force consisting of DEA, FBI, IRS, Homeland Security Investigations, NYPD and New York State Police. Management oversight over investigations over a 445 mile (716 kilometres), border with the Canadian provinces of Ontario and Quebec. It has 4 of the most heavily traveled border crossings between the countries including Buffalo-Niagara Falls, Champlain-Rouses Pt, Massena and Thousand Islands Bridge. -
Special Agent In Charge Detroit OfficeDrug Enforcement Administration Nov 2003 - Apr 2005Springfield, Virginia, UsDept of Justice Senior Executive Service. .Served as Chief Executive for the DEA’s 7th largest office, encompassing Michigan, Ohio and Kentucky. Management oversight over investigations involving a 721 mile, 1160 kilometer, border with the Canadian province of Ontario. All of the border crossings in this state rank among the top 10 highest volume crossings between the two countries. -
Associate Special Agent In Charge New York Drug Enforcment Task ForceDrug Enforcement Administration Sep 2002 - Nov 2003Springfield, Virginia, UsDept of Justice Senior Executive Service. Chief of the NY Drug Enforcement Task Force. Supervised domestic/international enforcement operations for nation’s largest drug task force comprised of 200+ members from DEA, New York City Police Department and New York State Police.
John P. Gilbride, Education Details
-
Seton Hall UniversityHuman Resource Training And Development -
Brookings Institution Executive EducationGovernment Policy -
Northeastern UniversityCriminal Justice/Police Science
Frequently Asked Questions about John P. Gilbride,
What company does John P. Gilbride, work for?
John P. Gilbride, works for Purdue Pharma L.p.
What is John P. Gilbride,'s role at the current company?
John P. Gilbride,'s current role is Director Ethics and Compliance at Purdue Pharma L.P..
What is John P. Gilbride,'s email address?
John P. Gilbride,'s email address is da****@****hoo.com
What schools did John P. Gilbride, attend?
John P. Gilbride, attended Seton Hall University, Brookings Institution Executive Education, Northeastern University.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial